» Articles » PMID: 10330145

Expression and Functional Characteristics of Calpain 3 Isoforms Generated Through Tissue-specific Transcriptional and Posttranscriptional Events

Overview
Journal Mol Cell Biol
Specialty Cell Biology
Date 1999 May 18
PMID 10330145
Citations 37
Authors
Affiliations
Soon will be listed here.
Abstract

Calpain 3 is a nonlysosomal cysteine protease whose biological functions remain unknown. We previously demonstrated that this protease is altered in limb girdle muscular dystrophy type 2A patients. Preliminary observations suggested that its gene is subjected to alternative splicing. In this paper, we characterize transcriptional and posttranscriptional events leading to alterations involving the NS, IS1, and IS2 regions and/or the calcium binding domains of the mouse calpain 3 gene (capn3). These events can be divided into three groups: (i) splicing of exons that preserve the translation frame, (ii) inclusion of two distinct intronic sequences between exons 16 and 17 that disrupt the frame and would lead, if translated, to a truncated protein lacking domain IV, and (iii) use of an alternative first exon specific to lens tissue. In addition, expression of these isoforms seems to be regulated. Investigation of the proteolytic activities and titin binding abilities of the translation products of some of these isoforms clearly indicated that removal of these different protein segments affects differentially the biochemical properties examined. In particular, removal of exon 6 impaired the autolytic but not fodrinolytic activity and loss of exon 16 led to an increased titin binding and a loss of fodrinolytic activity. These results are likely to impact our understanding of the pathophysiology of calpainopathies and the development of therapeutic strategies.

Citing Articles

Differences in alternative splicing events in the adaptive strategies of two Daphnia galeata genotypes induced by fish kairomones.

Choi T, Malik A, Han S, Kim C BMC Genomics. 2024; 25(1):725.

PMID: 39060996 PMC: 11282837. DOI: 10.1186/s12864-024-10643-1.


Novel Biomarkers for Limb Girdle Muscular Dystrophy (LGMD).

Aguti S, Gallus G, Bianchi S, Salvatore S, Rubegni A, Berti G Cells. 2024; 13(4.

PMID: 38391941 PMC: 10886967. DOI: 10.3390/cells13040329.


The Effects of Antioxidants and Pulsed Magnetic Fields on Slow and Fast Skeletal Muscle Atrophy Induced by Streptozotocin: A Preclinical Study.

Tastekin B, Pelit A, Sapmaz T, Celenk A, Majeed M, Mundkur L J Diabetes Res. 2023; 2023:6657869.

PMID: 38020198 PMC: 10661870. DOI: 10.1155/2023/6657869.


CAPN3: A muscle‑specific calpain with an important role in the pathogenesis of diseases (Review).

Chen L, Tang F, Gao H, Zhang X, Li X, Xiao D Int J Mol Med. 2021; 48(5).

PMID: 34549305 PMC: 8480384. DOI: 10.3892/ijmm.2021.5036.


Titin splicing regulates cardiotoxicity associated with calpain 3 gene therapy for limb-girdle muscular dystrophy type 2A.

Lostal W, Roudaut C, Faivre M, Charton K, Suel L, Bourg N Sci Transl Med. 2019; 11(520).

PMID: 31776291 PMC: 7397529. DOI: 10.1126/scitranslmed.aat6072.


References
1.
Kolmerer B, Olivieri N, Witt C, Herrmann B, Labeit S . Genomic organization of M line titin and its tissue-specific expression in two distinct isoforms. J Mol Biol. 1996; 256(3):556-63. DOI: 10.1006/jmbi.1996.0108. View

2.
Sorimachi H, Ishiura S, Suzuki K . Structure and physiological function of calpains. Biochem J. 1998; 328 ( Pt 3):721-32. PMC: 1218978. DOI: 10.1042/bj3280721. View

3.
Shapiro M, Senapathy P . RNA splice junctions of different classes of eukaryotes: sequence statistics and functional implications in gene expression. Nucleic Acids Res. 1987; 15(17):7155-74. PMC: 306199. DOI: 10.1093/nar/15.17.7155. View

4.
Saido T, Yokota M, Nagao S, Yamaura I, Tani E, Tsuchiya T . Spatial resolution of fodrin proteolysis in postischemic brain. J Biol Chem. 1993; 268(33):25239-43. View

5.
David L, Shearer T . Purification of calpain II from rat lens and determination of endogenous substrates. Exp Eye Res. 1986; 42(3):227-38. DOI: 10.1016/0014-4835(86)90057-6. View